ARES
Ares Management Corporation
There isn't enough reported data to score ARES yet.
BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
ARES Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| N/A | |
| N/A |
ARES's profitability is currently stable. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like ARES.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ARES PE Valuation
ARES has no meaningful PE right now: it lost money over the past year.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
ARES Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Strong growth | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ARES, but weaker profitability.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over ARES on the outlook, with more favorable profitability expectations.
ARES Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.53 | +220% |
| Q4 2024 | $2.04 | -16% |
| Q3 2024 | $2.20 | +1.4% |
| Q2 2024 | $1.95 | +18% |
| Q1 2024 | $2.26 | +102% |
| Q4 2023 | $2.42 | +178% |
| Q3 2023 | $2.17 | +136% |
| Q2 2023 | $1.65 | +3.8% |
| Q1 2023 | $1.12 | -46% |
BAC has the stronger earnings trend. Trailing diluted EPS is down 16% for ARES versus BAC up 14%.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
ARES Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $1.2B | +11% |
| Q3 2024 | $842M | +24% |
| Q2 2024 | $874.9M | +11% |
| Q1 2024 | $735.8M | +13% |
| Q4 2023 | $1.1B | +0.7% |
| Q3 2023 | $677.7M | +12% |
| Q2 2023 | $785.1M | +28% |
| Q1 2023 | $653.7M | +18% |
ARES has the stronger quarterly revenue trend. Revenue is up 71% for ARES versus up 6.7% for BAC.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | N/A |
| Q4 2024 | 32% | -11 points |
| Q3 2024 | 39% | +5.4 points |
| Q2 2024 | 36% | -12 points |
| Q1 2024 | 31% | -5.5 points |
| Q4 2023 | 43% | +12 points |
| Q3 2023 | 33% | +44 points |
| Q2 2023 | 49% | +38 points |
ARES's operating margin was 19% last quarter, down 12 points from the same quarter a year ago.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over ARES on profitability, with a higher operating margin.
ARES Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | $807.6M | +$1.4B |
| Q3 2024 | $841.3M | +164% |
| Q2 2024 | $432.2M | +$1.1B |
| Q1 2024 | $710M | +0.3% |
| Q4 2023 | -$560.1M | -$369.5M |
| Q3 2023 | $318.3M | +1194% |
| Q2 2023 | -$699.1M | +$93.3M |
| Q1 2023 | $707.6M | +216% |
ARES has the stronger cash trend. Its trailing FCF is up 484% versus its history, compared with BAC at up 119%.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
ARES Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +15% | +47.1M shares |
| 1 year | +16% | +50.6M shares |
| 3 years | +23% | +66.9M shares |
| 5 years | +46% | +113M shares |
ARES has 360M diluted shares, up 16% from a year ago.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over ARES on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ARES Net Leverage
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
ARES Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 54.4 | Neutral |
ARES's weekly RSI is 54 (neutral) and its Stochastic is 54 (neutral).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ARES PE vs Financial Services Sector
| Metric | ARES | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
ARES has no meaningful PE right now: it lost money over the past year.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
ARES Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $123.3 | 8.1% above |
| 20 week MA | $128.3 | 3.9% above |
| 50 week MA | $130.7 | 2% above |
| 100 week MA | $148.9 | 10% below |
| 200 week MA | $134.3 | 0.7% below |
ARES has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
ARES Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $34.8 | $49.1 | +41% |
| 2021 | $49.1 | $81.4 | +66% |
| 2022 | $81.4 | $67.7 | -17% |
| 2023 | $67.7 | $118.9 | +76% |
| 2024 | $118.9 | $179.5 | +51% |
| 2025 | $179.5 | $168.7 | -6% |
| 2026 YTD | $168.7 | $133.3 | -21% |
ARES has finished higher in four of the last six years, three of them by more than 50%. It's down 21% so far in 2026.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over ARES on returns for 2026, with the stronger performance.